137 related articles for article (PubMed ID: 23360272)
1. Rho as a target to promote repair: translation to clinical studies with cethrin.
McKerracher L; Guertin P
Curr Pharm Des; 2013; 19(24):4400-10. PubMed ID: 23360272
[TBL] [Abstract][Full Text] [Related]
2. A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury.
Fehlings MG; Theodore N; Harrop J; Maurais G; Kuntz C; Shaffrey CI; Kwon BK; Chapman J; Yee A; Tighe A; McKerracher L
J Neurotrauma; 2011 May; 28(5):787-96. PubMed ID: 21381984
[TBL] [Abstract][Full Text] [Related]
3. Rho-ROCK inhibition in the treatment of spinal cord injury.
Forgione N; Fehlings MG
World Neurosurg; 2014; 82(3-4):e535-9. PubMed ID: 23298675
[TBL] [Abstract][Full Text] [Related]
4. Rho Inhibitor VX-210 in Acute Traumatic Subaxial Cervical Spinal Cord Injury: Design of the SPinal Cord Injury Rho INhibition InvestiGation (SPRING) Clinical Trial.
Fehlings MG; Kim KD; Aarabi B; Rizzo M; Bond LM; McKerracher L; Vaccaro AR; Okonkwo DO
J Neurotrauma; 2018 May; 35(9):1049-1056. PubMed ID: 29316845
[TBL] [Abstract][Full Text] [Related]
5. Rho signaling pathway targeted to promote spinal cord repair.
Dergham P; Ellezam B; Essagian C; Avedissian H; Lubell WD; McKerracher L
J Neurosci; 2002 Aug; 22(15):6570-7. PubMed ID: 12151536
[TBL] [Abstract][Full Text] [Related]
6. Combined application of Rho-ROCKII and GSK-3β inhibitors exerts an improved protective effect on axonal regeneration in rats with spinal cord injury.
Zhang G; Lei F; Zhou Q; Feng D; Bai Y
Mol Med Rep; 2016 Dec; 14(6):5180-5188. PubMed ID: 27840930
[TBL] [Abstract][Full Text] [Related]
7. Analysis of recruitment and outcomes in the phase I/IIa Cethrin clinical trial for acute spinal cord injury.
McKerracher L; Anderson KD
J Neurotrauma; 2013 Nov; 30(21):1795-804. PubMed ID: 23844986
[TBL] [Abstract][Full Text] [Related]
8. Spinal cord injury and neural repair: focus on neuroregenerative approaches for spinal cord injury.
Baptiste DC; Tighe A; Fehlings MG
Expert Opin Investig Drugs; 2009 May; 18(5):663-73. PubMed ID: 19379122
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of Clostridium botulinum C3 exoenzyme.
Just I; Rohrbeck A; Huelsenbeck SC; Hoeltje M
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):247-52. PubMed ID: 21193903
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of bone marrow stromal cells and a Rho kinase (ROCK) inhibitor, fasudil on axon regeneration in rat spinal cord injury.
Chiba Y; Kuroda S; Shichinohe H; Hokari M; Osanai T; Maruichi K; Yano S; Hida K; Iwasaki Y
Neuropathology; 2010 Jun; 30(3):241-50. PubMed ID: 19925560
[TBL] [Abstract][Full Text] [Related]
11. Targeting Rho to stimulate repair after spinal cord injury.
McKerracher L; Higuchi H
J Neurotrauma; 2006; 23(3-4):309-17. PubMed ID: 16629618
[TBL] [Abstract][Full Text] [Related]
12. Rho signaling and axon regeneration.
McKerracher L; Ferraro GB; Fournier AE
Int Rev Neurobiol; 2012; 105():117-40. PubMed ID: 23206598
[TBL] [Abstract][Full Text] [Related]
13. Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo.
Peterson SL; Nguyen HX; Mendez OA; Anderson AJ
J Neurosci; 2015 Mar; 35(10):4332-49. PubMed ID: 25762679
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury.
Chan CC; Khodarahmi K; Liu J; Sutherland D; Oschipok LW; Steeves JD; Tetzlaff W
Exp Neurol; 2005 Dec; 196(2):352-64. PubMed ID: 16154567
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Controlled Trial of Local Delivery of a Rho Inhibitor (VX-210) in Patients with Acute Traumatic Cervical Spinal Cord Injury.
Fehlings MG; Chen Y; Aarabi B; Ahmad F; Anderson KD; Dumont T; Fourney DR; Harrop JS; Kim KD; Kwon BK; Lingam HK; Rizzo M; Shih LC; Tsai EC; Vaccaro A; McKerracher L
J Neurotrauma; 2021 Aug; 38(15):2065-2072. PubMed ID: 33559524
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of intracellular Rho to stimulate axon growth and regeneration.
Ellezam B; Dubreuil C; Winton M; Loy L; Dergham P; Sellés-Navarro I; McKerracher L
Prog Brain Res; 2002; 137():371-80. PubMed ID: 12440379
[TBL] [Abstract][Full Text] [Related]
17. Mevalonate Cascade and Small Rho GTPase in Spinal Cord Injury.
Eftekharpour E; Nagakannan P; Iqbal MA; Chen QM
Curr Mol Pharmacol; 2017; 10(2):141-151. PubMed ID: 26758952
[TBL] [Abstract][Full Text] [Related]
18. Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration.
Kubo T; Hata K; Yamaguchi A; Yamashita T
Curr Pharm Des; 2007; 13(24):2493-9. PubMed ID: 17692017
[TBL] [Abstract][Full Text] [Related]
19. Polysialic-Acid-Based Micelles Promote Neural Regeneration in Spinal Cord Injury Therapy.
Wang XJ; Peng CH; Zhang S; Xu XL; Shu GF; Qi J; Zhu YF; Xu DM; Kang XQ; Lu KJ; Jin FY; Yu RS; Ying XY; You J; Du YZ; Ji JS
Nano Lett; 2019 Feb; 19(2):829-838. PubMed ID: 30605619
[TBL] [Abstract][Full Text] [Related]
20. Clostridial C3 proteins: recent approaches to improve neuronal growth and regeneration.
Höltje M; Just I; Ahnert-Hilger G
Ann Anat; 2011 Jul; 193(4):314-20. PubMed ID: 21459564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
